Aclaris Therapeutics to Participate in Two June Healthcare Conferences
Aclaris Therapeutics (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on immuno-inflammatory diseases, has announced its participation in two major healthcare conferences in June 2025. The company's CEO Dr. Neal Walker and senior leadership team will participate in:
1. A fireside chat at the Jefferies Global Healthcare Conference in New York on June 4, 2025, at 10:30 AM EDT
2. A fireside chat at the 46th Annual Goldman Sachs Global Healthcare Conference in Miami on June 11, 2025, at 1:20 PM EDT
Live webcasts of both events will be available on the Events page of Aclaris' website and will remain accessible for at least 30 days.
Aclaris Therapeutics (NASDAQ: ACRS), un'azienda biofarmaceutica in fase clinica specializzata in malattie immuno-infiammatorie, ha annunciato la sua partecipazione a due importanti conferenze sanitarie nel giugno 2025. Il CEO dell'azienda, Dr. Neal Walker, insieme al team di leadership senior, parteciperà a:
1. Un incontro informale al Jefferies Global Healthcare Conference a New York il 4 giugno 2025 alle 10:30 EDT
2. Un incontro informale al 46° Annual Goldman Sachs Global Healthcare Conference a Miami l'11 giugno 2025 alle 13:20 EDT
Le dirette web di entrambi gli eventi saranno disponibili nella pagina Eventi del sito web di Aclaris e resteranno accessibili per almeno 30 giorni.
Aclaris Therapeutics (NASDAQ: ACRS), una compañía biofarmacéutica en etapa clínica enfocada en enfermedades inmuno-inflamatorias, ha anunciado su participación en dos importantes conferencias de salud en junio de 2025. El CEO de la compañía, Dr. Neal Walker, y el equipo de liderazgo senior participarán en:
1. Una charla informal en el Jefferies Global Healthcare Conference en Nueva York el 4 de junio de 2025 a las 10:30 AM EDT
2. Una charla informal en la 46ª Conferencia Anual Global de Salud de Goldman Sachs en Miami el 11 de junio de 2025 a la 1:20 PM EDT
Las transmisiones en vivo de ambos eventos estarán disponibles en la página de Eventos del sitio web de Aclaris y permanecerán accesibles por al menos 30 días.
Aclaris Therapeutics (NASDAQ: ACRS)는 면역 염증 질환에 중점을 둔 임상 단계의 바이오제약 회사로, 2025년 6월에 열리는 두 개의 주요 헬스케어 컨퍼런스에 참여할 것이라고 발표했습니다. 회사의 CEO 닐 워커 박사와 고위 경영진이 다음 행사에 참석합니다:
1. 2025년 6월 4일 오전 10시 30분(EDT), 뉴욕에서 열리는 Jefferies 글로벌 헬스케어 컨퍼런스에서의 파이어사이드 채팅
2. 2025년 6월 11일 오후 1시 20분(EDT), 마이애미에서 열리는 제46회 골드만 삭스 글로벌 헬스케어 컨퍼런스에서의 파이어사이드 채팅
두 행사 모두 라이브 웹캐스트가 Aclaris 웹사이트 이벤트 페이지에서 제공되며 최소 30일간 시청할 수 있습니다.
Aclaris Therapeutics (NASDAQ : ACRS), une société biopharmaceutique en phase clinique spécialisée dans les maladies immuno-inflammatoires, a annoncé sa participation à deux grandes conférences de santé en juin 2025. Le PDG, Dr Neal Walker, ainsi que l'équipe de direction senior, participeront à :
1. Une discussion informelle lors de la Jefferies Global Healthcare Conference à New York le 4 juin 2025 à 10h30 EDT
2. Une discussion informelle lors de la 46e conférence annuelle Goldman Sachs Global Healthcare Conference à Miami le 11 juin 2025 à 13h20 EDT
Les webcasts en direct des deux événements seront disponibles sur la page Événements du site web d'Aclaris et resteront accessibles pendant au moins 30 jours.
Aclaris Therapeutics (NASDAQ: ACRS), ein biopharmazeutisches Unternehmen in der klinischen Phase mit Schwerpunkt auf immun-entzündlichen Erkrankungen, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im Juni 2025 angekündigt. Der CEO Dr. Neal Walker und das Führungsteam des Unternehmens werden teilnehmen an:
1. Einem Fireside-Chat auf der Jefferies Global Healthcare Conference in New York am 4. Juni 2025 um 10:30 Uhr EDT
2. Einem Fireside-Chat auf der 46. jährlichen Goldman Sachs Global Healthcare Conference in Miami am 11. Juni 2025 um 13:20 Uhr EDT
Live-Webcasts beider Veranstaltungen werden auf der Veranstaltungsseite der Aclaris-Website verfügbar sein und mindestens 30 Tage lang zugänglich bleiben.
- None.
- None.
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will participate in two upcoming healthcare conferences in June.
- On Wednesday June 4, 2025, at 10:30 AM EDT, Aclaris’ Chief Executive Officer Dr. Neal Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during Jefferies Global Healthcare Conference in New York, NY.
- On Wednesday June 11, 2025, at 1:20 PM EDT, Dr. Walker and other members of Aclaris’ senior leadership team will participate in a fireside chat during the 46th Annual Goldman Sachs Global Healthcare Conference in Miami, FL.
A live and archived webcast of both events will be accessible on the Events page of https://www.aclaristx.com/. The webcasts will be available on the Aclaris website for at least 30 days.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of product candidates powered by a robust R&D engine. For additional information, please visit www.aclaristx.com and follow Aclaris on X (formerly Twitter) at @AclarisTx and on LinkedIn.
Aclaris Therapeutics Contact:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
FAQ
What conferences will Aclaris Therapeutics (ACRS) attend in June 2025?
When is Aclaris Therapeutics (ACRS) presenting at the Jefferies Global Healthcare Conference 2025?
Who will represent Aclaris Therapeutics (ACRS) at the upcoming June 2025 healthcare conferences?
How can investors access Aclaris Therapeutics' (ACRS) conference presentations in June 2025?
